Learn More
BACKGROUND Itolizumab, a humanized monoclonal antibody to CD6, is a novel therapeutic agent evaluated in chronic plaque psoriasis. OBJECTIVE We sought to assess the safety and efficacy of(More)
CONTEXT Gonorrhoea is one of the most common sexually transmitted infections (STI) in developing countries and is a global health problem. AIMS To analyze the trend of antimicrobial susceptibility(More)